Galmed Pharma (GLMD) Reports Q4 Loss of $0.40/Share

Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.40), versus ($0.29) reported last year.

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• UBS Downgrades EasyJet Plc. (EZJ:LN) (ESYJY) to Neutral
• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2